Atlas Trials

A Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's Macroglobulinemia

Clinical trial NCT00398710 · COMPLETED

Trial details

NCT number
NCT00398710
Sponsor
AEterna Zentaris
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Waldenström's Macroglobulinemia
Start date
2006-10-01
Primary completion
2011-08-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.